- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03105583
A Cross-sectional Study Evaluating Pregnancy Related Use of Vitamins and Medication (PREVIM)
This cross-sectional study will try to give answers to the following project aims:
- To provide an overview of the prevalence of health products' use among Belgian pregnant women (prescription and OTC medication, vitamin supplements, phyto-therapeutics, dermatologic products), including where pregnant women buy or get their health products (online web survey).
- To document women's beliefs about medication during pregnancy and their information desire (online web survey).
- To determine the current vitamin status among pregnant women and to reveal clinical targets for supplementing deficiencies in this population (blood sample analysis).
The study will be performed at the obstetrics department of the University Hospitals of Leuven (campus Gasthuisberg).
We aim to include 300 pregnant women (100 per trimester), of which 150 women will be asked to determine their vitamin status (50 per trimester).
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Pregnant women who visit the obstetrics department of the University Hospitals of Leuven (campus Gasthuisberg) will be invited to participate, independent of their pregnancy trimester.
Women can only participate once during their pregnancy.
Description
Inclusion Criteria:
- Pregnant women who visit the obstetrics department of the University Hospitals of Leuven
- ≥18 years
- Able to understand Dutch, French or English
Exclusion Criteria:
- <18 years
- Don't able to understand Dutch, French or English
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Pregnant women visiting the obstetrics department
|
Haemoglobin, RBC count + hematocrits, thrombocytes count, folate (serum), vitamin B12, WBC count, ferritin, iron (serum), transferrin % and saturation, TSH, T4, free glucose, LDH, ALT, AST, GGT, bilirubin (total), CRP, albumin, total protein, ureum, uric acid, creating, calcium (total), 25-hydroxy vitamin D, Na, K, Mg
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Medication and supplement use among Belgian pregnant women
Time Frame: Completion of a questionnaire during pregnancy: between 8-12weeks or 24-32weeks gestational age
|
Percentage of women who have taken a health product during the last 7 days - Overview of the health products used by pregnant women
|
Completion of a questionnaire during pregnancy: between 8-12weeks or 24-32weeks gestational age
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vitamin deficiencies among Belgian pregnant women
Time Frame: One blood sample during pregnancy: between 8-12weeks or 24-32weeks gestational age
|
Analysis of a blood sample
|
One blood sample during pregnancy: between 8-12weeks or 24-32weeks gestational age
|
Medication beliefs among Belgian pregnant women
Time Frame: Completion of a questionnaire during pregnancy: between 8-12weeks or 24-32weeks gestational age
|
Beliefs about Medicines Questionnaire (BMQ) (R. Horne, H. Nordeng)
|
Completion of a questionnaire during pregnancy: between 8-12weeks or 24-32weeks gestational age
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Veerle Foulon, PhD, PharmD, KU Leuven
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MC201602
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnant Women
-
Myant Medical Corp.McMaster UniversityNot yet recruiting
-
Qianfoshan HospitalShandong Nursing AssociationRecruiting
-
Brigham and Women's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingPregnant WomenUnited States
-
Sultan Abdulhamid Han Training and Research Hospital...RecruitingPregnant WomenTurkey
-
Sultan Abdulhamid Han Training and Research Hospital...Not yet recruiting
-
Alexandria UniversityCompleted
-
University of BeykentIstanbul University - Cerrahpasa (IUC)Completed
-
Anhui Provincial HospitalAalto UniversityCompleted
-
Assistance Publique - Hôpitaux de ParisCompleted
Clinical Trials on Medication use during pregnancy
-
University of WashingtonRecruitingNeurodevelopmental Disorders | PrematurityMalawi
-
Hospital do Servidor Publico EstadualMaternal Breastfeeding Incentive Center (CIAMA)Completed
-
University of PalermoRecruitingPregnancy Related | Uterine FibroidRussian Federation
-
Odense University HospitalCompleted
-
University of Illinois at Urbana-ChampaignIchuli Consulting LimitedUnknown
-
Seoul National University Bundang HospitalEnrolling by invitation
-
Instituto de Nutrición y Tecnología de los AlimentosPontificia Universidad Catolica de Chile; Servicio de Salud Metropolitano Sur...Active, not recruitingNutritional Status | Body Composition | Breast Density | Mental Health IssueChile
-
Universidad de GranadaCompletedHypertension | Obesity | Pregnancy | Gestational DiabetesSpain
-
University Hospital, LilleCompletedPregnancy, High RiskFrance
-
Central Hospital, Nancy, FranceRecruiting